For Europe, the Middle East and Africa (EMEA) Johnson & Johnson (J&J) set up an independent organization in 2007, the Johnson & Johnson Corporate Citizenship Trust (Trust). Trust is responsible for the initiation, set-up and management of socially responsible projects and activities in the EMEA region.
The organization demonstrates its dedication to the J&J Family of Companies in terms of improving the quality of life of people in society. Dedication which is also cited in the Trust mission - the achievement of sustainable and long-term improvement in the health of people by investing in strategic partnerships and innovative solutions which are valuable for both society and individuals.
The Trust, with its 2018 strategy launched in 2013, focuses on 3 areas: saving and improving lives of mothers and children; avoiding chronic diseases in vulnerable population groups; strengthening the capacity of healthcare staff. A strategy which focuses on sustainable long-term partnerships and knowledge sharing. In 2013 the Trust invested more than six million euros in partnerships and innovative solutions. For more information: www.jjcct.org.
Janssen contributed to different specific projects, often related to HIV/AIDS, a deep-rooted research domain within Janssen which has resulted in some breakthrough medicines. The impact of HIV/AIDS reaches far beyond the threat of individual lives. Janssen is also dedicated to offer sustainable help at this wider level. That is why Janssen supports the battle against HIV/AIDS through Pepal Leadership Challenge and Sikiliza Leo in Uganda and TAMA in India. Through Health2Wealth in Zambia the company wants to tackle diarrhea and in Romania the challenge is reducing the high hepatitis C infection level.